SPP1 and melanoma: Maier et al. determined OPN protein levels in the plasma of melanoma patients and found that OPN is a promising novel biomarker for the detection of metastatic tumors; these authors also concluded that the combination of plasma OPN levels with the well-established serological tumor marker S100 might enhance the prediction of melanoma metastasis [33].